| Everything you want to try in cardiac rehabilitation | | Pogosova, Nana (Moscow, Russian Federation)
| Rehabilitation and Exercise Physiology | 987-988-989-990 |
| The fight against sudden cardiac death. How to improve what we have? | | Wilkoff, Bruce (Cleveland, United States of America)
| Sudden Cardiac Death and Resuscitation | 894-895-896-897 |
| Pulmonary Hypertension in Left Heart Disease | | Lang, Irene & Gomez-Sanchez, Miguel
| Pulmonary Hypertension | 890-891-892-893 |
| What's new in cardiac pacing? | | Israel, Carsten (Frankfurt, Germany)
| Arrhythmias | 881-882-883-884-885 |
| Risk stratification in Brugada syndrome | | Wolpert, Christian (Mannheim, Germany)
| Arrhythmias | 871-872-873-874-875-876-877-878-879-880 |
| Fallacies from clinical trials | | Michel Bertrand (France)
| | 399-400-401-402 |
| Micro-RNAs in the heart: small molecules with major impact | |
Goumans, Marie-Jose (Leiden, Netherlands)
| Heart Failure (HF) | 375-376-377-378 |
| Progress in cardiac and vascular tissue engineering | | Harding, Sian E (London, United Kingdom)
| Chronic Ischaemic Heart Disease (IHD) | 3357-3358-3359-3360 |
| Graft arteriosclerosis: new insights | | Weis Michael (Munchen, Germany)
| Heart Failure (HF) | 3349-3350-3351-3352-3353 |
| Emerging concepts in the pathogenesis and management of atrial fibrillation | | Hatem, Stephane (Paris, France)
| Atrial Fibrillation | 3345-3346-3347-3348 |
| Percutaneous aortic valve implantation: a consensus between cardiologists and surgeons | | Maisano, Francesco (Segrate, Italy)
| Valvular Heart Diseases | 3275-3276-3277-3278 |
| The kidney in heart failure: les liaisons dangereuses | | Jondeau, Guillaume (Paris, France)
| Heart Failure (HF) | 3241-3242-3243-3244 |
| Myocarditis: update on imaging and contemporary management | | Schwitter, Juerg (Zurich, Switzerland)
| Myocardial Disease | 3222-3223-3224-3225 |
| Bicuspid aortic valve disease: an old disease with a new name? | | Stepinska, Janina (Warsaw, Poland)
| Valvular Heart Diseases | 305-306-307-308 |
| The strengths of the imaging modalities in coronary artery disease - changing roles | | Sochor, Heinz (Austria)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 278-279-280-281 |
| Cardiotoxicity of antineoplastic agents | | Minotti,Giorgio (Rome, Italy)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 261-262-263-264-265 |
| Safety of drug-eluting stents: two years after Barcelona | | Eeckhout, Eric (Lausanne, Switzerland)
| Invasive Imaging: Cardiac Catheterisation and Angiography | 2570-2571-2572-2573 |
| Structure/function relationships in the heart | | Richard, Sylvain (Montpellier, France)
| Basic Sciences | 2554-2555-2556-2557 |
| Unique contributions of cardiovascular magnetic resonance to diagnostic cardiology | | Lombardi, Massimo (Pisa, Italy)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 252-253-254-255-256 |
| Difficult mitral valve problems | | Al-Attar, Nawwar (Paris, France)
| Valvular Heart Diseases | 2474-2475-2476-2477 |
| The clinical relevance of myocardial necrosis during percutaneous coronary intervention | | Belardi, Jorge (Argentina)
| | 2465-2466-2467-2468 |
| 2008 ESC heart failure guidelines: what's new? | | Swedberg, Karl (Sweden)
| Heart Failure (HF) | 2442-2444-2445-2446 |
| The new ESC guidelines | | Vahanian, Alec (Paris, France)
| | 2407-2408-2409-2410 |
| INTERHEART - an update | | Giampaoli, Simona (Rome, Italy)
| | 2403-2406 |
| Heart failure and atrial fibrilation | | Blanc, Jean-Jacques (Brest, France)
| Atrial Fibrillation | 2331-2332-2333-2334 |
| Home monitoring for electrical devices | | Wilkoff, Bruce (Cleveland, United States)
| Arrhythmias | 2327-2328-2329-2330 |
| The gourmand's heart - a bitter sweet relationship? | | Sans Menendez, Susana (Barcelona, Spain)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 218-219-220-221 |
| Imaging valve disease in 2008 | | Hagege, Albert (Paris, France)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 1857-1858-1859-1860 |
| In vivo imaging for cardiac regeneration | | Van Echteld, Cees Ja (Oberwil,Switzerland)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 1835-1836-1837-1838 |
| The Monocyte: Much More than Just an Inflammatory Cell | | Pearson, Jeremy (United Kingdom)
| Myocardial Disease | 1831-1832-1833-1834 |
| Cardiac computed tomography in coronary artery disease: when to use and when not to use | | De Feyter, Pim J (Rotterdam, Netherlands)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 1706-1707-1708-1709 |
| Strategies to prevent sudden death in athletes | | Reiner, Zeljko (Zagreb, Croatia)
| Arrhythmias | 1668-1669-1670-1671-1672-1673-1674-1675-1676-1677 |
| Use and abuse of biomarkers in acute coronary syndromes | | Tubaro, Marco (Rome, Italy)
| Acute Coronary Syndromes (ACS) | 163-164-165-166 |
| How to improve the rate of responders with cardiac resynchronisation therapy? | | Glikson, Michael (Ramat Gan, Israel)
| Arrhythmias | 1594-1595-1596-1597-1598 |
| Advances in imaging and management of arrhythmogenic right ventricular cardiomyopathy | | Thiene, Gaetano (Italy)
| | 1578-1581 |
| Medical treatment of atrial fibrillation | | Le Heuzey, Jean Yves (Paris, France)
| Atrial Fibrillation | 147-148-149-150 |
| The post-ablation atrial fibrillation patient | | Jose Luis, Merino (Madrid, Spain)
| Atrial Fibrillation | 143-146 |
| Laminopathies affecting the heart: from clinical suspicion to correct treatment | | Pankuweit, Sabine (Marburg, Germany)
| Genetics | 134-135-136-137-138 |
| High-density lipoprotein and ApoA1-Milano – Full circle from bench to bedside | | Reiner, Zeljko (Croatia)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 1128-1129-1130-1131-1132-1133 |
| Breakthrough or aberration? Neovascularisation in cardiovascular disease | | Waltenberger, Johannes (Aachen, Germany)
| Chronic Ischaemic Heart Disease (IHD) | 1112-1113-1114-1115 |
| Heart Failure with Normal Ejection Fraction | | Guardigli, Gabriele (Italy)
| Heart Failure (HF) | 1017-1018-1019-1020 |